Sellas Life Sciences Group ISLS
13F holders, Q1 2024 (March 31)30holders
1famous investor
$1.01avg. 13F price*
At the end of Q1 2024, 30 institutions reported holding Sellas Life Sciences Group I (SLS) in their 13F filings. The largest holders were Anson Funds Management LP ($4.9M), Vanguard Group Inc. ($1.5M) and BlackRock Inc. ($281K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Sellas Life Sciences Group I
- CUSIP
- 81642T209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $5.0M |
| Exits | 8 | $1.3M |
Ownership 30 holders
| Anson Funds Management LP | 0.39% | New | 4,832,368 | $4.9M |
| Vanguard Group Inc. | 0.00% | Add +31.9% | 1,513,235 | $1.5M |
| BlackRock Inc. | 0.00% | Reduce -0.6% | 278,218 | $281K |
| Geode Capital Management, LLC | 0.00% | Add +11.2% | 273,063 | $276K |
| Opus Capital Group, LLC | 0.03% | Add +48.6% | 200,600 | $203K |
| Equitable Holdings, Inc. | 0.00% | Add +21.2% | 200,000 | $202K |
| State Street Corp. | 0.00% | No change | 97,129 | $98K |
| Northern Trust Corp. | 0.00% | Add +42.1% | 88,730 | $90K |
| Virtu Financial LLC | 0.00% | Reduce -34.2% | 39,429 | $40K |
| Prosperity Financial Group, Inc. | 0.02% | New | 25,385 | $26K |
| Mariner, LLC | 0.00% | New | 25,257 | $26K |
| Cantor Fitzgerald, L. P. | 0.01% | New | 24,750 | $25K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +287.1% | 20,725 | $21K |
| Independent Financial Group, LLC | 0.00% | No change | 20,250 | $20K |
| Citadel Advisors | 0.00% | New | 19,718 | $20K |
| XTX Topco Ltd | 0.00% | Reduce -59.1% | 17,391 | $18K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 16,238 | $16K |
| Commonwealth Equity Services, LLC | 0.00% | Add +13.2% | 14,054 | $14K |
| Brooklyn FI, LLC | 0.00% | New | 11,178 | $11K |
| Nemes Rush Group LLC | 0.00% | No change | 10,000 | $10K |
| JPMorgan Chase & Co. | 0.00% | Reduce -37.8% | 6,092 | $6K |
| Osaic Holdings, Inc. | 0.00% | No change | 1,660 | $2K |
| Morgan Stanley | 0.00% | No change | 1,420 | $1K |
| Wells Fargo & Company | 0.00% | Reduce -98.2% | 301 | $304 |
| Allworth Financial LP | 0.00% | No change | 150 | $152 |
| Janiczek Wealth Management, LLC | 0.00% | No change | 11 | $12 |
| Parkside Financial Bank & Trust | 0.00% | No change | 2 | $3 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $2 |
| FMR LLC | 0.00% | New | 1 | $1 |
| Royal Bank of Canada | 0.00% | Reduce -37.7% | 223 | $0 |
"% of holder's portfolio" is SLS's weight in each manager's 13F, not the share of Sellas Life Sciences Group I the manager owns.